SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-166675
Filing Date
2017-05-11
Accepted
2017-05-11 08:36:02
Documents
3
Period of Report
2017-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d354348d8k.htm 8-K 17037
2 EX-99.1 d354348dex991.htm EX-99.1 42057
3 GRAPHIC g354348g0511033913995.jpg GRAPHIC 3098
  Complete submission text file 0001193125-17-166675.txt   64617
Mailing Address AESCHENVORSTADT 36 BASEL V8 4051
Business Address AESCHENVORSTADT 36 BASEL V8 4051 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37923 | Film No.: 17832631
SIC: 2836 Biological Products, (No Diagnostic Substances)